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Antenatal IL-1-dependent 
inflammation persists postnatally 
and causes retinal and sub-retinal 
vasculopathy in progeny
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Antenatal inflammation as seen with chorioamnionitis is harmful to foetal/neonatal organ development 
including to eyes. Although the major pro-inflammatory cytokine IL-1β participates in retinopathy 
induced by hyperoxia (a predisposing factor to retinopathy of prematurity), the specific role of 
antenatal IL-1β associated with preterm birth (PTB) in retinal vasculopathy (independent of hyperoxia) 
is unknown. Using a murine model of PTB induced with IL-1β injection in utero, we studied consequent 
retinal and choroidal vascular development; in this process we evaluated the efficacy of IL-1R 
antagonists. Eyes of foetuses exposed only to IL-1β displayed high levels of pro-inflammatory genes, 
and a persistent postnatal infiltration of inflammatory cells. This prolonged inflammatory response was 
associated with: (1) a marked delay in retinal vessel growth; (2) long-lasting thinning of the choroid; 
and (3) long-term morphological and functional alterations of the retina. Antenatal administration of 
IL-1R antagonists – 101.10 (a modulator of IL-1R) more so than Kineret (competitive IL-1R antagonist) 
– prevented all deleterious effects of inflammation. This study unveils a key role for IL-1β, a major 
mediator of chorioamnionitis, in causing sustained ocular inflammation and perinatal vascular eye 
injury, and highlights the efficacy of antenatal 101.10 to suppress deleterious inflammation.
Preterm birth (PTB) still remains a major medical concern1. At present, PTB is a primary cause of infant mortal-
ity and morbidity in the USA and the rest of the world2,3. Globally, more than 10% of infants are born preterm, 
amounting to 15 million children worldwide4. Prematurity disrupts normal organogenesis; this applies to major 
organs such as lungs, brain, gut, and eyes5–7. Exposure to the higher extrauterine O2 concentrations (relative to 
those in utero) exerts toxicity to these neonatal organs, including for instance by impairing vessel growth in the 
eye thus predisposing to the development of retinopathy of prematurity (ROP)8.
Other perinatal conditions also contribute to foetal/neonatal organ damage. Along these lines, inflammation 
(as seen in chorioamnionitis) is reported to contribute to more than 60% of PTB prior to 28 weeks gestation9,10. 
Chorioamnionitis is also deleterious to many foetal/neonatal organs9,11, and can lead to foetal inflammatory 
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response syndrome (FIRS). Fragile endothelium is particularly vulnerable and a contributor to vascular dysfunc-
tion during acute and chronic inflammation12,13, such that FIRS has not only been linked to higher risks of brain 
injury14 but also of that to the retina15–18 by contributing to ROP19 and associated microvascular degeneration20 
and retinal dysfunctions21. Concurrently, inflammation is known to induce numerous cytotoxic mediators in 
endothelial cells22.
During infection and sterile inflammation, Toll-like receptors are activated by small molecular motifs 
on bacterial cell walls and/or by molecules released by stressed cells, which in turn induce the expression of 
pro-inflammatory cytokines and chemokines to further magnify the inflammatory cascade23. Inflammatory 
mediators activate uterine activation proteins, which will favour cervical ripening and foetal membrane weaken-
ing, and trigger contractions and labour23. Among the major pro-inflammatory cytokines Interleukin (IL)-6 and 
IL-8 concentrations dominate in the perinatal period24–26. However, IL-1β is a trigger and amplifier of the inflam-
matory cascade, including of IL-6 and IL-827,28. Accordingly, increased levels of IL-1β in the foetal compartment 
are observed with PTB in humans29,30, and polymorphisms of corresponding IL-1 gene pathways affect the risk 
of preterm birth31–33. IL-1β in turn contributes directly to prematurity34 and to foetal/neonatal injury35. In this 
context, IL-1β-dependent retinal and sub-retinal injury to the immature subject is clearly described and involves 
direct endothelial cytotoxicity36, but the associated inflammation is mostly secondary to post-natal alterations 
in oxygen exposure37–40. However other than epidemiological links and associated roles in other eye damaging 
conditions triggered by distinct mechanisms, notably oxidative stress, the direct role for IL-1β in causing injury 
to the retina/sub-retina of the immature subject is unknown. To discriminate the specific role of antenatal IL-1β 
(independent of hyperoxia - a predisposing factor to ROP) on oculo-vascular development we studied the effects 
of gestational IL-1β associated with foetal inflammatory response on development of retinal and choroidal ves-
sels. To ascertain the role of IL-1β we also desirably used two molecularly distinct IL-1R antagonists, specifically 
Kineret, a clinically-approved competitive inhibitor of IL-1R, and 101.10, an all-d heptapeptide (sequence: ryt-
vela) non-competitive inhibitor of IL-1R34,41,42; this approach was adopted since different pharmacologic agents 
may exhibit different properties. Our findings reveal an important role for antenatal IL-1β, a major mediator of 
chorioamnionitis, in causing prolonged ocular inflammation in the offspring resulting in damage to retinal and 
sub-retinal vasculature, structure and function; these deleterious effects were prevented by antenatal 101.10 to a 
greater extent than Kineret.
Methods
Animals. The use of timed-pregnant CD-1 mice for this study was first approved by the Animal Care 
Committee of Sainte-Justine’s Hospital following the principles of the Guide for the Care and Use of Experimental 
Animals developed by the Canadian Council on Animal Care. Animals were ordered from Charles River Inc., all 
having reached the 11th day of gestation. They were kept in the animal facility for a few days before starting the 
experiments to let them get used to their new environment. From their arrival to the end of the experiments, they 
had free access to chow and water, and were kept in a 12:12 light/dark cycle.
Chemical products. The following products were used: rhIL-1β (#200-01B; PeproTech, Rocky Hill, New 
Jersey), 101.10 (Elim Biopharmaceuticals, Hayward, California), Kineret (Sobi, Biovitrum Stockholm, Sweden) 
and RU-486 (Mifepristone; M8046; Sigma-Aldrich, Darmstadt, Germany).
Animal model of PTB induced by IL-1β. Pregnant CD-1 mice were injected subcutaneously in the neck 
at gestation day (G) 16.5 with 101.10 (1 mg/Kg/12 h), Kineret (4 mg/Kg/12 h [clinically recommended dose]) or 
vehicle (Fig. 1A), consistent with previous studies22. Half an hour later, mice were anaesthetized with isoflurane 
with a mask on the muzzle, which was kept during all interventions. With surgical scissors, a 1.5 cm cut was 
made in the abdomen to expose the uterine horns. An injection of rhIL-1β (1 μg) was made between two foetal 
membranes as reported42, being careful not to penetrate the amniotic cavity using transillumination; a schematic 
diagram is presented in Fig. 1B. Abdominal muscles were sutured and the skin was stapled shut. Pregnant dams 
were thoroughly examined every 2 h until term (G19–19.5) to observe the moment of birth and assess the health 
of newborns.
Animal model of PTB without inflammation. A single intraperitoneal injection of the progesterone 
receptor antagonist RU-486 (1 μg/kg) was made at G17. Mice were closely observed until parturition.
Prenatal tissue collection. To collect the foetal eyes during gestation, 3–5 mice/group were sacrificed at 
G17, G17.5 and G18. After anaesthesia with isoflurane, they were euthanized with CO2 and cervical dislocation. 
The same method of euthanasia was performed for all mice used in the following experiments. Caesarean sections 
were performed by widely opening the abdomen with surgical scissors and exposing uterine horns. Foetuses were 
extracted from their amniotic sacs, decapitated and their eyes were collected and snap-frozen in dry ice. They 
were preserved at −80 °C for further biochemical analyses.
Postnatal tissue collection. At birth, 6–8 pups were sacrificed, their eyes collected and quickly processed 
for biochemical analyses. After term (24 h after G19), 5–7 pups/group were sacrificed at post-term days (to adjust 
for prematurity) (Pt) 1, Pt 4, Pt 8, Pt 15, Pt 22 and Pt 30 to collect their eyes for histological experiments. The 
remaining pups were kept alive with their mother until weaning at 3 weeks old. They were then isolated for elec-
trophysiological experiments at Pt 30.
RNA extraction and Real-Time quantitative Polymerase Chain Reaction (RT-qPCR). Eyes col-
lected antenatally were submerged in 500 μL of Ribozol (AMRESCO, Solon OH, United States) either after dis-
section and isolation of retina and sub-retina, or as a whole, to prevent RNA degradation. Samples were then 
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homogenized and RNA was isolated as per manufacturer’s instructions. Using the spectrophotometer Nanodrop 
1000, RNA concentration and purity (ratio A260:A280 > 1.6) were measured. For each sample, 500 ng of RNA 
was converted into complementary DNA (cDNA) using the synthesis kit iScript Reverse Transcription Supermix 
(Bio-Rad; Hercules CA, United States). Primers were designed with NCBI Primer Blast. Gene expression was 
quantified with Stratagene MXPro3000 (Stratagene) with SYBR Green Master Mix (Bio-Rad). Gene expression 
levels were standardized with the universal primer 18 S (Ambion Life Technology; Burlington ON, Canada). 
Dissociation curves were obtained to verify primer specificity. We analysed the following genes: Il1b, Il6, Il8, Il12, 
Ccl2, Casp1, Tnfa, Il4, Il10 and Il27, as previously described22,28; primer sequences are detailed in Table 1.
Immuno-enzymology method ELISA. ELISA was performed as documented22,28 and as recommended 
by the manufacturer for the following kits: mouse IL-1β/IL-1F2 Quantikine (#MLB00C; R&D systems), mouse 
IL-6 Quantikine (#M6000B; R&D systems) and mouse IL-8 (#MBS261967; Mybiosource; recognizes the IL-8 
homologue CXCL2). Tissue was equally distributed and briefly lysed in a RIPA solution containing proteases to 
inhibit protein degradation. Each 50 μL sample was then loaded on a 96-well plate previously embedded with 
specific primary antibodies, then incubated for 2 hours at room temperature. Then, wells were washed 5 times 
and incubated for 2 hours with an enzyme-linked polyclonal secondary antibody. After further washes, substrate 
solution was added. Reaction was stopped after 30 min and plates were read at 450 nm with a wavelength correc-
tion of 570 nm.
Eye collection and fixation. Foetuses and pups (<Pt4) were decapitated or sacrificed with CO2 and cer-
vical dislocation (>Pt7). By pressing around the orbits with small scissors, eyes were pulled out of the skull 
Figure 1. Murine model of inflammation-induced PTB employed for the study. (A) IL-1β (1 µg) was 
administered intrauterine at G16.5, whereas 101.10 (1 mg/Kg/12 h), Kineret (4 mg/Kg/12 h) or vehicle were 
administered subcutaneously for 2 consecutive days, with the first dose administered 30 min prior to IL-1β. 
(B) Intrauterine injection of IL-1β was made between two foetal membranes, without penetrating the amniotic 
cavity.
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and collected by pinching the optic nerve. The cornea was pierced with a syringe and the eyes were fixated for 
20–30 min in PFA 4%, then transferred in PBS and preserved at 4 °C until they were processed for flat mounts or 
cryosections.
Immunofluorescence. Eyes were dissected to withdraw the cornea and the lens; the rest was fixated in 
sucrose 30% for 24 hours at 4 °C. They were then imbedded in Frozen Section Compound (FSC 22 Clear), 
snap-frozen in dry ice and sectioned with a cryostat at a thickness of 14 μm. Classical immunofluorescence tech-
nique was used with antibodies against lectin (Bandeiraea simplicifolia, Sigma-aldrich; 1:100), Iba-1 (ab5076, 
Abcam; 1:500) and Dapi (Invitrogen; 1:5000). Fluorescent secondary antibody was applied for the Iba-1 labelling 
(Alexa fluor 488, Abcam; 1:200). Images were taken with a confocal microscope (TCS SP2, Leica Microsystems) 
using a 20X objective.
Retinal and choroidal flat mounts. For each group, eyes of 5 mice at Pt1, Pt4, Pt8, Pt15, Pt21 and Pt30 
were dissected as reported43, to isolate the retina and choroid/retinal pigment epithelium (RPE) complex. Flat 
mounts were then labelled with a fluorescent antibody against lectin (Sigma-aldrich; 1:100) and Iba-1 (ab5076, 
Abcam; 1:500). Fluorescent secondary antibody was applied for the Iba-1 labelling (Alexa fluor 488, Abcam; 
1:200). On a microscope slide, 4 cuts were performed with a scalpel to flatten the retina and choroid/RPE com-
plex. With a paintbrush soaked with PBS, hyaloid vessels were removed. Images were obtained in confocal 
microscopy using a 20 × (lectin) or 100 × (Iba-1) objective. For Iba-1 imaging, the confocal was focused on the 
superficial retinal vascular layer at Pt 1 (corresponding to the nerve fibre layer [NFL]) and below the intermediate 
retinal vascular layer at Pt 15 and Pt 30 (corresponding to the INL)44.
Histological quantification. Vascular surface was measured with ImageJ and expressed in percentage of 
total retinal surface, and vessel density was analysed using ImageJ software in the mid-periphery of the retina, 
as described43. Briefly, lectin immunolabelling (blood vessels, showed as red on the retina) was isolated from 
other structures using the colour deconvolution tool in ImageJ. The detection threshold was established to reduce 
artefacts and a semi-quantitative comparison of vascular density was performed. Iba-1 positive (Iba1+) cells 
were counted using the ImageJ software in the central retina at Pt1 and in the mid-periphery at Pt15 and 30, as 
reported45.
In order to measure the thickness of the different retinal layers and of the choroid, ImageJ software was used to 
draw a line across the region to measure. Measures were taken at the central, middle and periphery of the retina 
and were repeated to obtain results that were more representative. A ratio was calculated for each eye to make a 
comparison between the groups. The retinal thickness was measured between the outer nuclear layer (ONL) and 
the ganglion cell layer (GCL) using the same method than the choroid, as we reported21,39,46.
Electroretinography. Electroretinogram (ERG) recording was performed with Espion ERG diagno-
sys machine with ColorDome Ganzfeld stimulator (Diagnosys LLC, Lowell, MA), as reported39. Mice were 
dark-adapted overnight and anesthetized prior to ERG with an intraperitoneal injection of Ketamine (100 mg/kg) 
and Xylazine (20 m/kg) mixture and mouse body temperature was kept at 37 °C using heated pad. DTL Plus 
electrodes (Diagnosys LLC) were positioned at the surface of the cornea after pupil’s dilatation with drops of 1% 
atropine and 2.5% phenylephrine (Alcon) and flash ERG were measured. Scotopic responses were simultaneously 
recorded at light intensity 0.9 cd-s/m². ERG was performed under red light in a dark room. After recording, eye 
hydration was carefully verified, and mice were kept at 37 °C until they awoke.
Statistical analysis. The term dam/group refers to the dams per group regardless of number of progeny 
(pups) of at least 1; hence n = 1 more for a single dam (with ≥1 progeny). Parametric analysis was performed 
since the power analysis is generally greater for continuous parametric variables, and given the spread of data 
between groups47. Comparisons between two variants was analysed by t-test. Comparisons between several 













Table 1. Forward and reverse sequences of primers used for RT-qPCR gene analysis.
www.nature.com/scientificreports/
5SCiEnTifiC REPORtS |  (2018) 8:11875  | DOI:10.1038/s41598-018-30087-4
used when many treatments were compared with one control. The value p < 0.05 was considered statistically 
significant. Data is presented as means ± S.E.M47.
Data availability. Data sets generated during this study can be obtained from the corresponding author 
upon request.
Results
In utero exposure to IL-1β causes an acute perinatal inflammatory response in the foetal retina 
and sub-retina. To study the retinal and sub-retinal vascular development in foetuses and pups after expo-
sure to IL-1β in utero, we employed an established murine model of IL-1β-induced chorioamnionitis34,42. As 
expected, intrauterine IL-1β (G16.5 days) shortened gestation and induced marked neonatal mortality; 101.10 
prolonged gestation to term and markedly augmented foetal survival (Suppl. Fig. 1); whereas Kineret exerted no 
protective effect, as previously reported34.
Eyes (undissected) of foetuses exhibited increased mRNA expression of pro-inflammatory mediators with 
a variable profile depending on timing after exposure to IL-1β-induced chorioamnionitis (Fig. 2A–C); at birth, 
increased protein levels of IL-1β, IL-6 and IL-8 were detected in the eyes (Fig. 2D–F); these were normalized by 
101.10, but not by Kineret with the exception of IL-8 attenuation. Interestingly, early (at G17.5) IL-1β-induced 
expression of anti-inflammatory Il27 was suppressed by Kineret but preserved by 101.10; while expression 
of Il10 was diminished by both Kineret and 101.10 (Suppl. Fig. 2). To better localize the intraocular inflam-
matory response, we isolated the retina and choroid of foetuses. IL-1β triggered early (G17.5) mRNA expres-
sion of Il1b, Il6, Il8, Il12, Ccl2 and Tnfa in retina more than in choroid (Fig. 2G,H), which was associated with 
increased intra-ocular accumulation of Iba1+ cells (activated macrophage/microglia)48 (Fig. 2I), as reported in 
inflammation-associated retinopathy49; this Iba1+ cell accumulation is clearly distinct from the relatively low 
level of Iba1+ cells in control animals wherein it plays a role in normal retinal development50. Notably, antenatal 
101.10 and Kineret significantly attenuated marked IL-1β-elicited cytokine induction and Iba1+ cell accumula-
tion (Fig. 2G–I).
Iba1+ cell accumulation persists post-natally in retina and choroid of newborns subjected in utero 
to inflammation. Abnormally high numbers of Iba1+ cells in retina over extended duration can affect vascu-
lar development and in turn cause long-term deficits of retinal function37. Since perinatal inflammation resulting 
in retinopathy is associated with prolonged inflammation37 with IL-1β-dependent microglial accumulation38, 
we determined if Iba1+ cells persisted in retina and choroid of animals exposed to IL-1β-induced chorioam-
nionitis. We detected a 3-fold increase in Iba1+ cell density on post-term (Pt) day 1 in eyes of animals exposed 
to antenatal IL-1β, which persisted on postnatal days 15 and 30 in retina and choroid (Fig. 3 and Suppl Fig. 3), 
consistent with previous observations related to early postnatal inflammation37; coincidentally, Il1b expression 
was increased from Pt 1 to Pt 15, and subsided by Pt 30 (Suppl. Fig. 4A) as inflammation resolved (in presence of 
Iba1+ cells)51,52. Inflammatory cell accumulation and Il1b expression was normalized by antenatal 101.10 (Fig. 3 
and Suppl Figs 3 and 4A).
Chorioamnionitis leads to persistent ocular inflammation in newborn offspring associated with 
impaired retinal vascular development and choroidal involution. Based on evidence of increased 
inflammation in retina and choroid in early weeks after birth we evaluated the impact of chorioamnionitis on 
retinal vessel growth and choroidal thickness in pups. Retinal vascularized surface area during the first postnatal 
week was reduced in animals subjected to IL-1β-induced chorioamnionitis (consistent with previous reports53) 
(Fig. 4A,B), but by Pt 8 retinal surface was fully vascularized in all groups as vessels reached the periphery 
(Fig. 4C); concordantly, Il1b expression was only marginally increased at Pt 8 (p < 0.06 vs sham-treated; Suppl. 
Fig. 4A). On the other hand, a small decrease in pan-retinal vascular density was detected in mice exposed to 
chorioamnionitis at Pt 8, which corresponds to the period wherein intra-retinal vessels are actively forming. This 
hypo-vascularization was aggravated at Pt 15 (Fig. 4D) when Il1b (mRNA) expression markedly rose (Suppl. 
Fig. 4A); ultimately retinal vascularization normalized at Pt 30 (Suppl. Fig. 4B) along with Il1b (mRNA) expres-
sion (Suppl. Fig. 4A). Antenatal 101.10 fully rescued retinal vascularization at all ages analysed, whereas Kineret 
was only partially effective at Pt 1 and ineffective subsequently at Pt 4, Pt 8 and Pt 15 (Fig. 4).
Since the choroid is an exclusive blood supply to the outer retina and its involution was recently linked to ROP 
and retinal functional deficits39,46, we measured choroid thickness. As anticipated, choroid thickness was normal 
soon after IL-1β treatment (at G17.5) (Suppl. Fig. 4C). By Pt 1 choroidal thinning was observed; these changes 
persisted beyond the neonatal period (at Pt 21) (Fig. 5A,B). Antenatal 101.10, but not Kineret, preserved choroi-
dal (normal) thickness.
To demonstrate that the effects of IL-1β are unrelated to prematurity per se, we showed that PTB induced with 
the progesterone receptor antagonist RU486 did not significantly affect ocular cytokine profile or postnatal vascu-
lar development (Suppl. Fig. 5), inferring an important role for perinatal inflammation on the latter.
Retinal structural and functional deficits in offspring secondary to gestational tissue-triggered 
inflammation. Retinal development depends upon normal blood supply54, such that both retinal structure 
and function are affected by vasculopathy as seen in ROP21,39. Accordingly, we measured retinal thickness from 
the outer neuroblastic layer to the nerve fibre layer at G17.5 and Pt 1, and between the ONL and the GCL at Pt 21 
(of the same eyes used to assess choroidal thickness). As expected39, full retinal thickness was not affected within 
the first 2 weeks after antenatal-induced inflammation (Fig. 5C). By Pt 15, following retinal vasculopathy (Fig. 4), 
there was a tendency for decreased thickness of the retina (Suppl. Fig. 6A), which was significantly manifested at 
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Pt 21 (Fig. 5D), and was largely attributed to thinning of the inner nuclear layer (Fig. 5F and Suppl. Fig. 6B); this 
resulted in a corresponding decreased b-wave amplitude (largely contributed by the inner nuclear layer) (Fig. 6). 
The ONL thickness and corresponding a-wave amplitude remained intact at the end of the first postnatal month 
(Figs 5E and 6), as reported in ROP-associated choroidopathy39. Retinal morphometry and inner retinal function 
were fully preserved by antenatal 101.10, but only partially by Kineret.
Figure 2. Inflammatory response in the retina and sub-retina of the foetus and newborn. (A–C) Foetal eyes 
were collected at G17 (A), G17.5 (B) and G18 (C) after in utero exposure to IL-1β to perform quantitative PCR. 
Results are relative to 18 S and plotted as fold change vs. the control groups. n = 3–8 dams/group; 4 foetal eyes 
per sample. (D–F) Cytokine levels in eyes of newborns exposed to the indicated treatments in utero (Fig. 1). 
n = 4 dams/group; 4 eyes per sample. (G–H) Quantitative PCR of IL-1, IL-6 and IL-8 performed on isolated 
retina (G) and choroid (H) collected on foetuses at G17.5; n = 3 dams/group; 10 retinas or sub-retinas per 
sample. (I) Iba-1-stained cryosections of retina from foetuses at G17.5 exposed to the indicated treatments in 
utero; n = 3 foetuses/group. Kin refers to Kineret. Scale bar, 300 μm. Values are presented as mean ± S.E.M. 
*p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Dunnett’s post-analysis.
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Discussion
Gestational inflammation is an independent risk factor for the development of neonatal morbidities, including 
to the eye11,16,19. Yet, the identification of a causal factor playing a pivotal role remains a challenge. Studies have 
suggested that the pro-inflammatory cytokine IL-1β is involved in the pathophysiology of many perinatal com-
plications55,56. A link between chorioamnionitis and neonatal brain injury is described19, and associated with 
vascular damage42. Of relevance, IL-1β plays a critical role in central nervous system insult during the perinatal 
period42,57,58. In retinal injury the role of IL-1β has mostly been ascribed to inflammation resulting from exposure 
to hyperoxia37–40, an important predisposing factor to ROP. However, there is still no evidence demonstrating a 
direct role for IL-1β in retinal/sub-retinal injury of the immature subject. Given that retinal damage represents 
a major complication of prematurity, itself often associated with inflammation, we set out to discriminate the 
effects of antenatal (intra-uterine) IL-1β-triggered inflammation on retinal and sub-retinal vascular development 
in offspring during the perinatal period and adolescence; in this process we also determined the efficacy of 101.10 
(compared to Kineret). By inducing utero-placental inflammation as reported34,42 with intra-uterine IL-1β (which 
does not cross the placental barrier59), we found a prolonged inflammation in the eye that begins ante-natally and 
ensues in choroidal and retinal vascular, structural and ultimately sustained functional deficits; these detrimental 
changes were prevented by antenatal 101.10 (but not [recommended dose of] Kineret).
Figure 3. Infiltration of immune cells in eyes during development of the pups. (A–C) Quantification of iba-1+ 
cells observed on retinal and choroidal flat mounts at Pt 1 (A), Pt 15 (B) and Pt 30 (C). n = 3–6 pup/group for 
each time point. Values are presented as mean ± S.E.M. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by 
one-way ANOVA with Dunnett’s post-analysis.
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The cascade of inflammatory mediators amplified by IL-1β exerts cytotoxicity on its own. As alluded to 
above macrophage/microglial invasion is a major contributor of IL-1β generation which in turn exerts endothe-
lial cytotoxicity via neuronally-generated Semaphorin3A38, and causes direct neurotoxicity including to pho-
toreceptors60,61. In cultured retinal endothelial cells, chronic exposure (5 days) to IL-1β leads to increased 
caspase-3 activity and apoptosis36. Concordantly, inhibition of IL-1β signalling using pharmacological or genetic 
approaches decreases caspase activity and apoptosis in retina, and prevents microvascular degeneration in 
hyperglycaemia-induced retinopathy models62. Comparably, IL-12 is a cytokine produced by macrophages, neu-
trophils, and other inflammatory cells, and acts by triggering T-cell differentiation63; IL-12 exhibits antiangiogenic 
properties64, and has been associated with serious ocular diseases including uveitis65. Interestingly, IL-1-induced 
Figure 4. Delay of retinal vessel growth in progeny. (A–C) Lectin-stained flat-mounts of retinas from pups 
at Pt 1 (A), Pt 4 (B) and Pt 8 (C) previously exposed in utero to the indicated treatments (Fig. 1). Images are 
representative of 3 to 5 separate pups per treatment group. Dotted lines depict the vascular front. Scale bar for 
A, 1500 μm; scale bar for B, 2500 μm; scale bar for C, 3000 μm. Right panels show quantification of the vascular 
area, n = 3–5 dams/group. (D) Magnification of lectin-stained flat-mounts of retinas from pups at Pt15 showing 
vascular density. Images are representative of 5 to 8 separate pups per treatment group. Scale bar, 150 μm. Right 
panel shows quantification of the vascular area at Pt8 and Pt15, n = 5–8 dams/group. Values are presented as 
mean ± S.E.M. *p < 0.05, ***p < 0.001 by one-way ANOVA with Dunnett’s post-analysis.
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Figure 5. Choroidal thinning precedes retinal degeneration and thinning of the inner nuclear layer. (A–B) 
Representative images (top panels) and quantification (bottom panels) of lectin-stained cross-sections of 
choroids from pups at Pt 1 (A) and Pt 21 (B) previously exposed to the indicated treatments in utero (Fig. 1). 
Vertical bars represent the average choroidal thickness. Scale bar for A, 30 μm; scale bar for B, 50 μm. n = 3–4 
pups/group. (C,D) Representative images (top panels) and quantification (bottom panels) of DAPI-stained 
cross-sections of retinas from pups at Pt1 (C) and Pt21 (D) previously exposed to the indicated treatments in 
utero (Fig. 1); n = 3–4 pups/group. Vertical bars represent the average retinal thickness. Scale bar for C, 250 μm; 
scale bar for B, 500 μm. (E,F) Quantification of DAPI-stained cross-sections of the ONL (E) and INL (F) from 
the same retinas measured in D. Values are presented as mean ± S.E.M. *p < 0.05, **p < 0.01, ***p < 0.001 by 
one-way ANOVA with Dunnett’s post-analysis. ONBL, outer neuroblastic layer; INBL, inner neuroblastic layer; 
NFL, nerve fibre layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, 
inner plexiform layer; GCL, ganglion cell layer.
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IL-12 retinal production was inhibited by 101.10 which may represent an additional mechanism through which 
101.10 protects retinal vasculature. The role of TNF in cytotoxicity is more complex as it depends on the receptor 
it acts upon which may convey opposing actions66,67.
In addition to retinopathy, choroidopathy has lately also been regularly observed in subjects formerly afflicted 
with ROP as recently reviewed68,69; and this feature was recently reproduced in models of ROP39. Involution of 
the choroid was found to be sustained and subsequently led to retinal pigment epithelium and photoreceptor 
degeneration39. In this context, IL-1β exerts a major contribution to choroidal thinning of the newborn subjected 
to perinatal oxidative stress, which in turn results in long-term injury to the sub- and outer retina. In line with 
this concept, we observed sustained presence of inflammatory cells post-natally, resulting in choroidal thinning 
as early as Pt 1, which we had found to predispose to subsequent photoreceptor injury. Together, current and 
previous observations39 related respectively to antenatal and postnatal inflammation and ensued retinal damage, 
reveal efficacy of anti-IL-1β treatment. Our findings are consistent with brain neuronal cell death of pups exposed 
to IL-1β-induced chorioamnionitis42. Hence, chorioamnionitis triggers an inflammatory cascade that spreads to 
the foetus causing retinal and choroidal injury.
An important feature reported herein is the long-term deficit in retinal structure (inner nuclear layer thin-
ning) and function caused by exposure to IL-1β in utero, despite recovery of retinal vascular density at Pt 30 
which coincided with abated IL-1β expression, consistent with diminished expression of inflammatory cytokines 
in residing macrophages upon resolution of the pro-inflammatory state51,52. Inner retinal functional deficits 
(depicted by b-wave amplitude suppression) are well described in former ROP subjects and believed to result 
prominently from retino-vascular injury21,68. Although we also observed early involution of the choroid upon 
exposure to utero-placental inflammation, time is needed until developmentally increased photoreceptor metab-
olism can no longer be supported by insufficient O2 and nutrient supply from the damaged choroid, resulting 
in photoreceptor damage39. Hence, we surmise a gradual degeneration of photoreceptors (and retinal pigment 
epithelium) after exposure to antenatal inflammation. Together, the retinal and sub-retinal damage observed in 
response to antenatal IL-1β are indicative of an important role for inflammation, found to be prolonged.
A relevant aspect of this study applies to the efficacy of 101.10 compared to Kineret in protecting the choroid 
and retina. We recently showed that inhibition of IL-1 receptor using a novel small peptide labelled 101.10 was 
fully effective in preventing PTB, improving survival and preserving foetal lung, gut and brain integrity42; whereas 
current commercially available IL-1 receptor antagonist (namely Kineret) were mostly ineffective. These find-
ings represented an unparalleled therapeutic which improved foetal/newborn outcome. Kineret is a competitive 
antagonist of the IL-1 receptor. Doses utilized corresponded to those clinically recommended (4 mg/kg/dose). 
Although higher doses of Kineret are more effective, a 7-fold-increase in dosage is needed to augment gesta-
tion and ensuing foetal maturation42, which would seriously compromise immune response, an established side 
effect of Kineret. As a competitive antagonist of IL-1 receptor Kineret suppresses both JNK/p38/c-jun/AP-1 and 
NF-κB pathways; whereas 101.10 acts as a modulator that biases IL-1R-induced signal transduction resulting 
in inhibition of the JNK/p38/c-jun/AP-1 pathway, while desirably preserving the NF-κB pathway23,34, impor-
tant for immune vigilance70,71. Along these lines, in contrast to Kineret, 101.10 maintained activity of some 
endogenous anti-inflammatory cytokines, notably IL-27 known to neutralize macrophage activity72, thus aug-
menting its anti-inflammatory activity; interestingly, IL-10 release is p38-dependent73 and IL-27 generation is 
NF-kB-dependent74, consistent with signalling actions of 101.10 and Kineret. Another disadvantage of Kineret 
applies to its relatively large size (17.5 kDa) curtailing passage across the placental barrier to sufficiently block 
inflammation in the foetal compartment59; whereas 101.10 is a small molecule (0.85 kDa) that can distribute in 
gestational tissues42, consistent with its preferred antenatal efficacy in suppressing detrimental inflammation and 
preserving foetal organ integrity.
Figure 6. Electroretinogram readings after completion of ocular development. (A) Representative ERG 
response of pups at Pt 30 previously exposed to the indicated treatments in utero (Fig. 1). (B,C) a-wave 
amplitude (B) and latency (C) of scotopic ERGs of corresponding animals. (D,E) b-wave amplitude (D) 
and latency (E) of scotopic ERGs of corresponding animals. n = 8–22 pups/group. Values are presented as 
mean ± S.E.M. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Dunnett’s post-analysis.
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In summary, this study unveils an unprecedented key role for IL-1β during gestation in the development of 
long-lasting inflammation and injury to the eye of the progeny, independently of prematurity per se. Antenatal 
inflammation as seen in chorioamnionitis induces damage to the choroid and retinal vasculature, structure and 
function, all of which is remarkably preserved by the small IL-1 receptor modulator 101.10. 101.10 could rep-
resent a novel therapeutic approach not only to tackle PTB34 but also in preventing major foetal/neonatal organ 
injury including to the eye of premature subjects exposed to antenatal inflammation.
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